Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.
Press releases published on April 25, 2025
Tevogen Bio Announces 2025 Annual Meeting
GlobeNewswire
·
April 25, 2025
WARREN, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen Bio” or “Company”) (Nasdaq: TVGN) today announced that the Company will hold its 2025 annual meeting of stockholders (the “Annual Meeting”) via live webcast at 11 a.m. …
Ecocyclic and enespa Partner to Launch State-of-the-Art Recycling Facility in Winnie, Texas
EIN Presswire
·
April 25, 2025
Ecocyclic and enespa join forces to build a high-tech chemical recycling plant in Texas, turning plastic waste into sustainable, circular raw materials WINNIE, TX, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Ecocyclic, a Texas-based …
N2 Infotech commercializes AI-based elevator predictive maintenance solution: Expanding market on public institutions
EIN Presswire
·
April 25, 2025
N2 Infotech rolls out an AI-based elevator maintenance system that targets public institutions with smart, usage-based predictive tech for global expansion. PANGYO, GYEONGGI-DO, SOUTH KOREA, April 25, 2025 /EINPresswire.com/ -- A predictive maintenance …
Colle AI Increases Platform Speed With Targeted Core Upgrades
EIN Presswire
·
April 25, 2025
Backend improvements reduce latency, improve AI response time, and accelerate NFT processing across chains LONDON , LONDON, UNITED KINGDOM, April 25, 2025 /EINPresswire.com/ -- Colle AI (COLLE), the multichain AI-NFT platform, has completed a series of …
iMyFone MirrorTo Enhances Mobile-to-PC Screen Mirroring for Professionals, Educators, and Gamers
EIN Presswire
·
April 25, 2025
NY, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- iMyFone has announced improvements to MirrorTo, its cross-platform screen mirroring solution that enables users to connect and control Android and iOS devices from their PC or Mac. Designed for …
CHINAPLAS 2025 Concluded with Impressive Results - Over 280,000 Industry Elites Gathered at the Stage of Innovation
EIN Presswire
·
April 25, 2025
SHENZHEN, CHINA, April 25, 2025 /EINPresswire.com/ -- CHINAPLAS 2025 successfully wrapped up on April 18 with 281,206 visitors (an increment of 13.29% compared to CHINAPLAS 2023 in Shenzhen) in 4 days. Among them, visitors from overseas countries and …
Introducing the ELECFREAKS micro:bit Nezha Pro Sports Kit: Bringing Robotics to Life Through Play
EIN Presswire
·
April 25, 2025
ELECFREAKS Nezha Pro Sports Kit: Build …
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
GlobeNewswire
·
April 25, 2025
Gene signatures associated with increased efficacy of micvotabart pelidotin (MICVO) due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders Mouse analog of MICVO in a syngeneic model …
AGII Refines Blockchain Speed With Real-Time Smart Contract Logic
EIN Presswire
·
April 25, 2025
Enhancing Web3 Through Instantaneous Execution and Scalable Contract Automation SEATTLE, WA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- AGII, the intelligent Web3 platform powered by advanced AI, announced a breakthrough refinement in smart …
Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 25, 2025
PARAMUS, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today the presentation of positive data …
ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma
GlobeNewswire
·
April 25, 2025
- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide (R2) was well-tolerated and demonstrated promising anti-tumor activity - Combination …
IMA360 Achieves 112% Revenue Growth and Expands Partnerships with McKesson and BRP
EIN Presswire
·
April 25, 2025
IRVING, TX, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- IMA360, a Texas-based provider of cloud-native profit optimization solutions, is pleased to announce it has recorded a 112% revenue growth in its 2024 fiscal year, in addition to acquiring …
WaveSpeedAI Secures Multi-Million Dollar Funding to Build the Fastest Infrastructure for AI Image and Video Generation
EIN Presswire
·
April 25, 2025
WaveSpeedAI secures multimillion-dollar funding to optimize its proprietary inference engine and accelerate next-gen multimodal AI infrastructure. SINGAPORE, SINGAPORE, April 25, 2025 /EINPresswire.com/ -- WaveSpeedAI, a global leader in multimodal AI …
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
GlobeNewswire
·
April 25, 2025
– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep and durable responses in hard-to-treat …
Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025
GlobeNewswire
·
April 25, 2025
Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection, boosts specificity and predictive value Presentations further validate the …
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
GlobeNewswire
·
April 25, 2025
Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 VANCOUVER, British Columbia, April …
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
GlobeNewswire
·
April 25, 2025
BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed …
Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
GlobeNewswire
·
April 25, 2025
Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancer Patient recruitment ongoing in Phase 1 trial of OP-3136 as a monotherapy and in …
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170
GlobeNewswire
·
April 25, 2025
Preclinical data further support the potential of dual-antigen and TGF-β-directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage …
Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets
GlobeNewswire
·
April 25, 2025
Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour BRAF degrader demonstrates broad activity across all three BRAF mutation classes Aurora A kinase …